Still More Mylan (MYL) Execs Load Up Shares
Tweet
Share
E-mailGet Alerts MYL Hot Sheet
Join SI Premium – FREE
This morning, Mylan Laboratories (NYSE: MYL) COO Heather Bresch and Director Rodney Piatt disclosed purchases of 5,000 shares each on 03/10.
Bresch and Piatt join the CEO, CFO and Chief Legal Officer who have also recently disclosed purchases. None of the buys has been over 30,000 shares.
Mylan, a generic drug maker, have suffered a crisis of confidence with shares trading at multi-year lows. The recent insider buying is likely to show the market that management is positive about the long-term prospects of the company. Still, despite the insider buying, the stock has done little. [LJ]
Link To Other Insider Trades�at Mylan
Bresch and Piatt join the CEO, CFO and Chief Legal Officer who have also recently disclosed purchases. None of the buys has been over 30,000 shares.
Mylan, a generic drug maker, have suffered a crisis of confidence with shares trading at multi-year lows. The recent insider buying is likely to show the market that management is positive about the long-term prospects of the company. Still, despite the insider buying, the stock has done little. [LJ]
Link To Other Insider Trades�at Mylan
You May Also Be Interested In
Create E-mail Alert Related Categories
Insider Trades, Insiders' BlogSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
